( HongKong:2269 )

News from WuXi Biologics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Aug 22, 2017, 02:03 ET WuXi Biologics Announces 2017 Interim Results

WuXi Biologics (Cayman) Inc. ("WuXi Biologics" or "the Group", stock code: 2269.HK), a leading global open-access biologics technology platform...


Aug 17, 2017, 07:22 ET WuXi Biologics and Gloria Pharmaceuticals Announce the Licensure of the Fully Human PD-1 Antibody, GLS-010, to Arcus Biosciences

WuXi Biologics (2269.HK), a global leading open-access biologics technology platform company offering end-to-end solutions for biologics discovery,...


Jun 12, 2017, 21:56 ET WuXi Biologics is Officially Listed on the Hong Kong Stock Exchange

On June 13, 2017 Hong Kong time, WuXi Biologics (Cayman) Inc. ("the Company"; stock code: 2269.HK) was officially listed during a grand listing...